Revvity PE Ratio 2010-2024 | RVTY
Current and historical p/e ratio for Revvity (RVTY) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Revvity PE ratio as of June 24, 2024 is 23.37.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Revvity PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-06-24 | 106.90 | 88.35 | |
2024-03-31 | 104.93 | $1.21 | 86.72 |
2023-12-31 | 109.16 | $5.50 | 19.85 |
2023-09-30 | 110.47 | $5.95 | 18.57 |
2023-06-30 | 118.48 | $6.54 | 18.12 |
2023-03-31 | 132.84 | $7.68 | 17.30 |
2022-12-31 | 139.71 | $4.58 | 30.50 |
2022-09-30 | 119.82 | $4.90 | 24.45 |
2022-06-30 | 141.55 | $5.34 | 26.51 |
2022-03-31 | 173.57 | $6.11 | 28.41 |
2021-12-31 | 199.95 | $8.08 | 24.75 |
2021-09-30 | 172.27 | $10.05 | 17.14 |
2021-06-30 | 153.43 | $10.51 | 14.60 |
2021-03-31 | 127.41 | $9.55 | 13.34 |
2020-12-31 | 142.45 | $6.76 | 21.07 |
2020-09-30 | 124.52 | $3.90 | 31.93 |
2020-06-30 | 97.25 | $2.95 | 32.97 |
2019-12-31 | 96.12 | $2.04 | 47.12 |
2019-09-30 | 84.24 | $2.10 | 40.11 |
2019-06-30 | 95.22 | $1.88 | 50.65 |
2019-03-31 | 95.17 | $1.95 | 48.80 |
2018-12-31 | 77.51 | $2.20 | 35.23 |
2020-03-31 | 74.57 | $1.79 | 41.66 |
2018-09-30 | 95.91 | $1.12 | 85.63 |
2018-06-30 | 72.14 | $1.25 | 57.71 |
2018-03-31 | 74.53 | $2.52 | 29.57 |
2017-12-31 | 71.90 | $2.64 | 27.24 |
2017-09-30 | 67.76 | $3.60 | 18.82 |
2017-06-30 | 66.87 | $3.31 | 20.20 |
2017-03-31 | 56.91 | $2.05 | 27.76 |
2016-12-31 | 51.05 | $2.13 | 23.97 |
2016-09-30 | 54.85 | $2.15 | 25.51 |
2016-06-30 | 51.18 | $2.10 | 24.37 |
2016-03-31 | 48.23 | $1.95 | 24.73 |
2015-12-31 | 52.15 | $1.88 | 27.74 |
2015-09-30 | 44.68 | $1.54 | 29.01 |
2015-06-30 | 51.11 | $1.43 | 35.74 |
2015-03-31 | 49.58 | $1.44 | 34.43 |
2014-12-31 | 42.33 | $1.38 | 30.67 |
2014-09-30 | 42.13 | $1.68 | 25.08 |
2014-06-30 | 45.19 | $1.67 | 27.06 |
2014-03-31 | 43.40 | $1.48 | 29.33 |
2013-12-31 | 39.65 | $1.04 | 38.13 |
2013-09-30 | 36.23 | $0.73 | 49.64 |
2013-06-30 | 31.13 | $0.66 | 47.17 |
2012-12-31 | 30.28 | $0.61 | 49.63 |
2012-09-30 | 28.05 | $-0.00 | 0.00 |
2012-06-30 | 24.49 | $0.02 | 1224.31 |
2012-03-31 | 26.18 | $0.04 | 654.56 |
2011-12-31 | 18.87 | $0.09 | 209.72 |
2013-03-31 | 32.16 | $1.04 | 30.92 |
2011-09-30 | 18.06 | $3.22 | 5.61 |
2011-06-30 | 25.23 | $3.02 | 8.36 |
2011-03-31 | 24.57 | $3.26 | 7.54 |
2010-12-31 | 24.08 | $3.27 | 7.36 |
2010-09-30 | 21.52 | $1.15 | 18.71 |
2010-06-30 | 19.15 | $1.16 | 16.51 |
2010-03-31 | 22.08 | $0.85 | 25.97 |
2009-12-31 | 18.96 | $0.73 | 25.97 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $13.324B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.209B | 15.59 |
Cencora (COR) | United States | $47.206B | 18.40 |
ICON (ICLR) | Ireland | $26.298B | 24.83 |
DiDi Global (DIDIY) | China | $21.580B | 0.00 |
Avantor (AVTR) | United States | $15.025B | 22.12 |
CochLear (CHEOY) | Australia | $14.104B | 0.00 |
Natera (NTRA) | United States | $13.153B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.518B | 41.19 |
Viatris (VTRS) | United States | $12.466B | 3.73 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.906B | 0.00 |
Charles River Laboratories (CRL) | United States | $10.900B | 20.87 |
Solventum (SOLV) | United States | $9.041B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.666B | 0.00 |
HealthEquity (HQY) | United States | $7.278B | 46.73 |
Organon (OGN) | United States | $5.359B | 5.08 |
Bausch + Lomb (BLCO) | Canada | $5.253B | 21.03 |
Doximity (DOCS) | United States | $5.103B | 35.74 |
PACS (PACS) | United States | $4.437B | 0.00 |
Life Times (LTH) | United States | $3.659B | 38.33 |
Sotera Health (SHC) | United States | $3.400B | 16.68 |
Surgery Partners (SGRY) | United States | $3.113B | 28.48 |
GoodRx Holdings (GDRX) | United States | $2.900B | 110.43 |
Agilon Health (AGL) | United States | $2.681B | 0.00 |
Progyny (PGNY) | United States | $2.462B | 42.39 |
NovoCure (NVCR) | Jersey | $2.052B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.013B | 7.98 |
Premier (PINC) | United States | $1.950B | 8.34 |
BrightSpring Health Services (BTSG) | United States | $1.819B | 0.00 |
Teladoc Health (TDOC) | United States | $1.647B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.141B | 0.00 | |
CareDx (CDNA) | United States | $0.732B | 0.00 |
Embecta (EMBC) | United States | $0.721B | 4.91 |
GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
Pediatrix Medical (MD) | United States | $0.673B | 7.14 |
InnovAge Holding (INNV) | United States | $0.646B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
Sharecare (SHCR) | United States | $0.497B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
Enhabit (EHAB) | United States | $0.428B | 42.70 |
COMPASS Pathways (CMPS) | United Kingdom | $0.427B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
ModivCare (MODV) | United States | $0.368B | 6.88 |
DocGo (DCGO) | United States | $0.314B | 17.17 |
LifeMD (LFMD) | United States | $0.289B | 0.00 |
MultiPlan (MPLN) | United States | $0.236B | 0.00 |
Beauty Health (SKIN) | United States | $0.221B | 0.00 |
Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
Biodesix (BDSX) | United States | $0.196B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
So-Young (SY) | China | $0.108B | 52.00 |
Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 5.72 |
IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
Oncology Institute (TOI) | United States | $0.033B | 0.00 |
Nutex Health (NUTX) | United States | $0.028B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.026B | 0.00 |
OncoCyte (OCX) | United States | $0.023B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
KindlyMD (KDLY) | $0.017B | 0.00 | |
BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
ISpecimen (ISPC) | United States | $0.005B | 0.00 |
DermTech (DMTK) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
OpGen (OPGN) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Assure Holdings (IONM) | United States | $0.002B | 0.00 |